Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report

INTRODUCTION: Intrahepatic cholangiocarcinoma (ICC) accounts for 10% to 15% of all primary hepatic carcinomas. However, there are no effective drug treatment strategies against ICC, and surgery is currently the only curative treatment. Here, we present a case of ICC successfully treated with anlotin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Aixia, Liu, Bin, Xu, Dandan, Sun, Yahong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946271/
https://www.ncbi.nlm.nih.gov/pubmed/31876723
http://dx.doi.org/10.1097/MD.0000000000018435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946271/
https://www.ncbi.nlm.nih.gov/pubmed/31876723
http://dx.doi.org/10.1097/MD.0000000000018435

Ejemplares similares